Patients with pancreatic cancer participating in clinical trials: are targets being met, and if not, why?
Affiliation
Cancer Research UK Department, Medical Oncology, Christie Hospital, ManchesterIssue Date
2007-03
Metadata
Show full item recordCitation
Patients with pancreatic cancer participating in clinical trials: are targets being met, and if not, why? 2007, 34(2):269-70 PancreasJournal
PancreasDOI
10.1097/01.mpa.0000250132.49403.abPubMed ID
17312469Type
ArticleLanguage
enISSN
0885-3177ae974a485f413a2113503eed53cd6c53
10.1097/01.mpa.0000250132.49403.ab
Scopus Count
Collections
Related articles
- [Adverse event and countermeasure with regard to FOLFIRINOX for pancreatic cancer].
- Authors: Koga F, Ueno H, Morizane C, Kondo S, Sakamoto Y, Okusaka T
- Issue date: 2015 Feb
- Antibody-drug conjugate may inhibit pancreatic cancer.
- Issue date: 2013 Dec
- Irreversible electroporation: a novel pancreatic cancer therapy.
- Authors: Weiss MJ, Wolfgang CL
- Issue date: 2013 Sep-Oct
- Pancreatic cancer: a plea for more trials.
- Authors: Van Cutsem E, Fevery J
- Issue date: 1995 Jun
- Weekly mitoxantrone in the treatment of advanced pancreatic carcinoma: a Southeastern Cancer Study Group Trial.
- Authors: DeSimone PA, Gams R, Bartolucci A
- Issue date: 1986 Jul